J&J Oral Psoriasis Therapy Holds 70% Clear Rate at Two Years
Johnson & Johnson's investigational oral psoriasis pill held clear or almost clear skin in at least 70% of patients at two years, per long-term extension data circulated by Stock Titan this week.